NeoplasiaCancer BiologyPeer-reviewed journal article
The Copy-Number Events in Skull Base Chordoma Stratify Tumours into Four Biologically Coherent Groups
Szymon BaluszekiD, Paulina KoberiD, Renata WoronieckaiD, Natalia Maławska, Michał WągrodzkiiD, Jacek KunickiiD, Tomasz MandatiD, Beata GrygalewicziD, Mateusz BujkoiD
Abstract
Chordoma, a rare sarcoma of notochordal origin, exhibits slow growth and local aggressiveness. While copy-number (CN) events are recognized as key chordoma drivers, no comprehensive classification, based on CN, has yet been developed. Here, we establish a robust, reproducible genomic subtyping of chordoma, based on CN events. Two independent skull base chordoma cohorts (N=32,N=71) were analyzed, utilizing distinct analytical platforms, DNA methylation microarrays and whole-genome sequencing, both controlled for B-allele frequencies. Samples were clustered using unsupervised hierarchical methods. The CN events defined four consistent molecular clusters across both cohorts: C1 (CN-stable), C9 (chromosomal losses, especially of chr9/CDKN2A), C7 (chr7 gain), and C2 (gains of chr2 and chr7). The findings were validated in fluorescence in situ hybridization (FISH) with concordance of 84-89%. The CN clusters explain 31-33% of the RNA-sequencing transcriptional variance. Moreover, the C2 cluster showed up-regulation of Sonic Hedgehog signaling and clusters C2 and C9 were enriched in cell-cycle-related genes. The proposed CN clusters correlate with existing chordoma classificators e.g. chromosomal instability (CIN), mutation burden, immune score, and methylation clusters. Furthermore, comparison with over 2,000 sarcomas highlighted CN patterns more common in chordoma (i.e. chr1q, chr2, chr7 gains and chr1p, chr3, chr9, chr10, chr13, chr14, chr18 losses) but also revealed shared aberrations, e.g. chr22 loss shared with Gastrointestinal Stromal Tumours (GISTs). This study provides a unifying classification for skull base chordoma, linking distinct genomic architectures to specific transcriptional programs and potential therapeutic vulnerabilities.
- organism: human
- assay: whole-genome sequencing
- assay: DNA methylation
- research focus: clustering
- research focus: gene regulatory network inference
- research focus: cell type annotation
- approach: statistical model
- approach: experimental assay
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 42th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- DNA methylation, combined with RNA sequencing, provide novel insight into molecular classification of chordomas and their microenvironment
S. P. Baluszek, P. Kober, … M. P. Bujko·bioRxiv·May 6, 2023
- Global Cluster Analysis and Network Visualization in Chordoma: A Scientometric Mapping
B.-W. Zheng, B.-Y. Zheng, … F.-S. Liu·bioRxiv·Nov 19, 2023
- Personalized chordoma organoids for drug discovery studies
A. Al Shihabi, A. Davarifar, … A. Soragni·bioRxiv·May 27, 2021
- Chromothripsis-like patterns are recurring but heterogeneously distributed features in a survey of 22,347 cancer genome screens
Haoyang Cai, Nitin Kumar, … Michael Baudis·bioRxiv·Jan 13, 2014
- A human neural crest model reveals the developmental impact of neuroblastoma-associated chromosomal aberrations
I. M. Saldana-Guerrero, L. F. Montano-Gutierrez, … F. Halbritter·bioRxiv·Nov 21, 2022
- Mapping the landscape of genetic dependencies in chordoma
T. Sharifnia, M. J. Wawer, … S. L. Schreiber·bioRxiv·Aug 17, 2022